Total planned funding: $411,396,719
Allocations
Countries/Regions
Eswatini | $411,396,719 |
Organizational Types
Private Contractor | $98,677,141 |
Unknown | $81,623,063 |
NGO | $73,927,712 |
University | $69,560,611 |
Own Agency | $49,233,968 |
FBO | $13,230,009 |
Host Country Government Agency | $12,644,827 |
Multi-lateral Agency | $9,689,694 |
Other USG Agency | $2,590,094 |
Implementing Agency | $219,600 |
Program Areas
Care | $123,654,097 |
Treatment | $99,975,378 |
Prevention | $80,647,088 |
Governance and Systems | $47,170,189 |
Testing | $30,771,852 |
Management and Operations | $29,178,115 |
Budget Codes
HTXS: Treatment: Adult Treatment | $79,709,672 |
HBHC: Care: Adult Care and Support | $49,467,968 |
HKID: Care: Orphans and Vulnerable Children | $41,925,970 |
HVCT: Testing: HIV Testing and Counseling | $30,771,852 |
HVMS: Management and Operations | $29,178,115 |
HVOP: Sexual Prevention: Other Sexual Prevention | $28,540,274 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $25,219,114 |
HVSI: Strategic Information | $22,575,179 |
HVTB: Care: TB/HIV | $21,310,209 |
OHSS: Health Systems Strengthening | $17,375,383 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $12,624,743 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $11,870,986 |
HTXD: Treatment: ARV Drugs | $10,958,150 |
PDCS: Care: Pediatric Care and Support | $10,949,950 |
PDTX: Treatment: Pediatric Treatment | $9,307,556 |
HLAB: Laboratory Infrastructure | $7,219,627 |
HMBL: Biomedical Prevention: Blood Safety | $2,391,971 |
HMIN: Biomedical Prevention: Injection Safety | $0 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $0 |
Top Partner Programs
Not Available:
$63,313,197
Countries/Regions
Columbia University:
$57,777,235
Countries/Regions
Pact, Inc.:
$46,593,405
Countries/Regions
Chemonics International:
$22,700,973
Countries/Regions